(Q30369081)

21 June 2017

1 reference

title

Human infection with highly pathogenic H5N1 influenza virus. (English)

1 reference

21 June 2017

5

Yoshihiro Kawaoka

1 reference

21 June 2017

3

Menno D de Jong

1 reference

21 June 2017

4

Gabriele Neumann

1 reference

21 June 2017

Andrea Gambotto

1

1 reference

21 June 2017

Simon M Barratt-Boyes

series ordinal

2

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

21 June 2017

1 reference

21 June 2017

volume

371

1 reference

21 June 2017

issue

9622

1 reference

21 June 2017

page(s)

1464-1475

1 reference

Predictability and preparedness in influenza control

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Preparing for the next pandemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Public health. Public health risk from the avian H5N1 influenza epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian influenza A (H5N1) infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Human disease from influenza A (H5N1), Thailand, 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian influenza A (H5N1) in 10 patients in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Experimental study to determine if low-pathogenicity and high-pathogenicity avian influenza viruses can be present in chicken breast and thigh meat following intranasal virus inoculation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian influenza H5N1 in tigers and leopards

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian H5N1 influenza in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian influenza H5N1 in naturally infected domestic cat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Influenza A H5N1 replication sites in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Influenza A/H5N1 virus infection in humans in Cambodia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Probable person-to-person transmission of avian influenza A (H5N1)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Oseltamivir resistance during treatment of influenza A (H5N1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Three Indonesian clusters of H5N1 virus infection in 2005

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Family clustering of avian influenza A (H5N1)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian influenza A (H5N1) infection in eastern Turkey in 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Re-emergence of fatal human influenza A subtype H5N1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

The first confirmed human case of avian influenza A (H5N1) in Mainland China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Encephalitis and encephalopathy associated with an influenza epidemic in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

H5N1 influenza A virus and infected human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

H5N1 infection of the respiratory tract and beyond: a molecular pathology study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Differential Expression of Chemokines and Their Receptors in Adult and Neonatal Macrophages Infected with Human or Avian Influenza Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian influenza H5N1 and healthcare workers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Low frequency of poultry-to-human H5NI virus transmission, southern Cambodia, 2005

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian flu: isolation of drug-resistant H5N1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Pandemic Threat Posed by Avian Influenza A Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

The molecular biology of influenza virus pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Influenza virus A pathogenicity: the pivotal role of hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Activation of influenza A viruses by trypsin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

1 reference

7 January 2021

The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Host-range barrier of influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Differential sensitivity of human, avian, and equine influenza a viruses to a glycoprotein inhibitor of infection: Selection of receptor specific variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Receptor binding properties of human and animal H1 influenza virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian flu: influenza virus receptors in the human airway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

H5N1 Virus Attachment to Lower Respiratory Tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Human influenza virus A/HongKong/156/97 (H5N1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

A single gene determines the host range of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

A single amino acid in the PB2 gene of influenza A virus is a determinant of host range.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Molecular aspects of avian influenza (H5N1) viruses isolated from humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Avian flu: H5N1 virus outbreak in migratory waterfowl.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Highly pathogenic H5N1 influenza virus infection in migratory birds

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Viruses and interferon: a fight for supremacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Pathology of fatal human infection associated with avian influenza A H5N1 virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Neurovirulence of influenza virus in mice. II. Mechanism of virulence as studied in a neuroblastoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Neurovirulence of influenza virus in mice. I. Neurovirulence of recombinants between virulent and avirulent virus strains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

A novel mechanism for the acquisition of virulence by a human influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Biologic importance of neuraminidase stalk length in influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Functional balance between haemagglutinin and neuraminidase in influenza virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Cell-mediated protection in influenza infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Development of effective vaccines against pandemic influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Trials of Influenza A/New Jersey/76 Virus Vaccine in Normal Children: An Overview of Age-Related Antigenicity and Reactogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

1 reference

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Epidermal DNA vaccine for influenza is immunogenic in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Developing vaccines against pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960627-3

7 January 2021

10.1016/S0140-6736(08)60627-3

Identifiers

DOI

1 reference

21 June 2017

1 reference